Citi Jane Fraser Adopts Warren Buffett Leadership Guidance
Citi's leadership under Jane Fraser is embracing Buffett-inspired rules to manage friction, keep decisions measured, ...
Articles — Page 1970
Brooklyn to Harvard at 16: The Former Goldman Sachs Leader
From public housing in Brooklyn to Harvard at 16 and a 12-year Goldman Sachs tenure, the former Goldman Sachs leader ...
Treasure Hunter Freed After a Decade: Ship of Gold Saga Rebounds
A once-celebrated treasure hunter exits federal custody after a decade behind bars, as investors weigh the legal fall...
Signs Emerge Thaw Housing Market Marks a Turn in 2026
A noticeable shift is forming in the housing market as early 2026 data show momentum building. Prices are stabilizing...
Monday Reads for Investors: Top 10 Essential Morning Briefs
Start your week with a proven investing ritual. This guide delivers 10 Monday reads—practical, data-driven, and ready...
Quentin Tarantino Fires Back: A Money Mindset Guide
A public clash between a legendary director and a veteran actor isn’t just drama. It’s a window into how money, reput...
Jersey Realtors Calls Graduated Fee Relief Amid Slowing Market
New Jersey Realtors is pressing lawmakers to reform or repeal the Graduated Percent Fee on residential sales, arguing...
Mortgage Credit Availability Rises in February, MBA
In February, the Mortgage Credit Availability Index rose 1.1% to 107.1, signaling looser lending in conventional prog...
This Billionaire Tesla Bull Bets Big on Nvidia Stock
A major stake in Nvidia from a notable Tesla bull underscores confidence in the AI chip leader’s growth trajectory, e...
Wall Street Turns Bullish on Three Financials Fresh Ratings
Compass Point flags three financials fresh ratings: wall on UWMC, RKT, and SLRC as rates ease and lending activity is...
Short Sellers Betting Against Intel Intensifies in Dow
Intel remains the Dow's most shorted stock as fresh data show rising short interest amid continued cash burn in the f...
Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...